Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

FOUNDATION MEDICINE, INC.

Subsidiary ofROCHE HOLDING AGUEI: EHXPZ92G4AD1CAGE: 73CG0

FOUNDATION MEDICINE, INC. is a federal contractor, registered under UEI EHXPZ92G4AD1 and CAGE code 73CG0. It has been awarded $157,920,080 across 61 federal contracts. Primary work spans Medical Laboratories. Top awarding agencies include Department Of Veterans Affairs and Other agencies (2 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

EHXPZ92G4AD1

CAGE Code

73CG0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

202X

NAICS Codes

621511Medical Laboratories(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Foundation Medicine, Inc. specializes in advanced genomic testing and molecular diagnostics for precision oncology, delivering next-generation sequencing (NGS) and molecular tumor profiling services to support clinical decision-making. Their core capabilities encompass comprehensive genomic profilin...

Foundation Medicine, Inc. specializes in advanced genomic testing and molecular diagnostics for precision oncology, delivering next-generation sequencing (NGS) and molecular tumor profiling services to support clinical decision-making. Their core capabilities encompass comprehensive genomic profiling of solid and hematologic malignancies, including tumor mutational burden analysis, microsatellite instability assessment, and fusion detection via NGS platforms. The contractor provides FDA-authorized, CLIA-certified laboratory services that enable personalized treatment pathways, with deep expertise in interpreting complex genomic data for therapeutic selection and clinical trial matching. Their technical differentiation lies in scalable, high-throughput genomic analytics tailored for real-world clinical environments, ensuring rapid turnaround and actionable insights for oncologists and care teams. The company maintains a consistent, long-standing relationship with the Department of Veterans Affairs, delivering genomic sequencing and molecular laboratory services across multiple VA medical centers. Work includes routine genomic testing for hematologic and solid tumors, as well as specialized services aligned with executive orders on precision medicine, demonstrating a trusted, repeat partnership focused on improving veteran cancer care through advanced diagnostics. Foundation Medicine operates primarily under NAICS 621511, which defines medical laboratories providing clinical diagnostic services. Their market positioning centers on precision oncology diagnostics within the federal healthcare system, serving as a specialized provider of molecular pathology services that bridge genomic research and clinical oncology practice. As a privately held entity headquartered in Cambridge, Massachusetts, Foundation Medicine operates as a non-certified small business with no federal small business certifications on record. The company’s physical and operational presence is anchored in Massachusetts, supporting federal healthcare missions through its accredited laboratory infrastructure and clinical bioinformatics capabilities.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Veterans Affairs$157.9M100%
Other agencies (2 agencies, <0.5% each)$27.9K0%
Awards by NAICS
621511 - Medical Laboratories$157.9M100%
Awards by Agency Over Time
Awards by Place of Performance

Open opportunities in FOUNDATION MEDICINE, INC.'s top NAICS codes and agencies

NAICS: 621511
New
Federal
Q301--36C259-26-AP-1918 | Prostate Testing Non-Invasive | VISN Contract
Solicitation # 36C25926Q0515
Solicitation 36C25926Q0515, issued by the Department of Veterans Affairs Network Contract Office 19, is a combined synopsis and solicitation for a five-year Blanket Purchase Agreement to provide non-invasive, urine-based molecular prostate cancer testing services for VISN 19 facilities. The contract, categorized under NAICS 621511, requires the contractor to provide test kits, shipping, analytical laboratory testing, result interpretation, and consultative services. All results must be delivered within five business days of sample receipt, and the contractor must maintain compliance with CLIA, CLSI, HIPAA, and Medicare/Medicaid regulations. The period of performance is scheduled from September 25, 2026, through September 24, 2031, with an initial quantity of 340 units. Amendment 0001 has modified the procurement to be unrestricted, removing all previous small business set-aside provisions and clauses, including those related to notice of total small business set-aside and limitations on subcontracting. Consequently, all responsible sources are eligible to submit quotes. The response deadline for this requirement is September 2, 2026. Submissions must include technical capabilities, pricing, and past performance documentation via the provided questionnaire. The primary point of contact for this effort is Contracting Officer Alejandra Sierra.
Network Contract Office 19 (36C259)

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 621511
New
Federal
BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan
Solicitation # HT941026Q2050
The contract is a Blanket Purchase Agreement (BPA) for Medical Laboratory Testing Services at the 18th Medical Group on Kadena Air Base, Japan, issued under solicitation number HT941026Q2050 by the Defense Health Agency Hcd West, Department of Defense. The BPA has a total ceiling value of $50,000 over its five-year period of performance from October 1, 2026, to September 30, 2031, and is structured as a firm-fixed-price agreement for specific laboratory tests including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The solicitation is unrestricted and invites full and open competition under NAICS code 621511. Contractors must submit a single PDF quotation that includes a capabilities statement addressing technical requirements from the Statement of Work, a completed Quote Sheet with firm-fixed pricing for each line item, and all required representations and certifications. Past performance and technical capability are critical evaluation factors, with technical capability serving as a mandatory pass/fail gate; failure to meet the technical threshold disqualifies a respondent. The evaluation is conducted on a best value basis with past performance carrying greater weight than price. Quote submissions are due by August 11, 2026, and must be emailed to the point of contact, April Delmendo. Performance is required on-site at the 18th Medical Group Laboratory in Building 626, Room LK08, during business hours of 7:30 a.m. to 4:30 p.m., Monday through Friday, excluding U.S. government holidays. The contractor must handle specimen collection daily within these hours, ensuring each sample includes the date, test name, patient name, and last four digits of the patient’s Social Security Number. The contractor is responsible for maintaining current laboratory accreditation, implementing a safety plan compliant with OSHA and Japan Environmental Governing Standards (JEGS), and ensuring all personnel have the necessary military base access credentials with background screening. Contractor staff must wear visible identification at all times and are prohibited from using retired or reserve military titles. Invoicing and payment will be processed electronically via the Wide Area Workflow system with specific routing and DoDAAC codes assigned. The contractor holds full liability for environmental incidents, property damage, and personnel injury, with mandatory reporting within one hour. The contract incorporates numerous FAR clauses related to cybersecurity, trafficking in persons, small
Defense Health Agency Hcd West

POSTED

3 days ago

DEADLINE

in 11 days
View Details
NAICS: 621511
Federal
J065--Mass Spectrometry Maintenance
Solicitation # 36C25926Q0764
The Department of Veterans Affairs, Veterans Health Administration, is conducting market research through a Sources Sought Notice to identify potential contractors for mass spectrometry maintenance at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado. The requirement involves providing scheduled, unscheduled, and periodic preventative maintenance inspections for various Agilent equipment, including Triple Quadrupole LC/MS systems, Infinity II pumps, multisamplers, thermostats, and workstations, as well as Peak Scientific nitrogen gas generators. The proposed period of performance begins on November 1, 2026, and includes a base year followed by four optional one-year periods, extending through October 31, 2031. Interested industry partners must submit a response that includes a capabilities statement, an overview of proposed solutions, and a completed market research questionnaire. Responses must be submitted via email to the designated contracting officer no later than 15:00 MST on September 3, 2026. The notice specifies that this is for planning purposes only and does not constitute a formal solicitation or a commitment to award a contract. The government has identified NAICS code 621511 for this requirement and requires detailed information regarding business size, GSA contract status, and compliance with the Buy American Act and subcontracting limitations.
Network Contract Office 19 (36C259)

POSTED

8 days ago

DEADLINE

in 6 days
View Details